Archives

by in
Entry Author Date Location
Arena Adds $35.5M 03/29/11 San Diego
Canaan Strings Together Some Good News, Just as the Pressure Mounts on VC Model 03/24/11 San Francisco
Who’s Going to Pay for Future Drug Development? (Part 2) 03/23/11 National
Who’s Going to Pay for Future Drug Development? (Part 1) 03/22/11 National
Think Obamacare Will Suffocate New Drug Development With Price Controls? Think Again 03/21/11 National
Affymax Raises $50M 03/18/11 San Francisco
Exelixis Tacks on $23M 03/15/11 San Francisco
Solazyme Seeks $100M IPO to Build Up Renewable Biofuel Business 03/14/11 San Francisco
Exelixis Bags $156M, Tethys Bets on Prevention, UCSF’s Delicate Dance With Industry, & More Bay Area Life Sciences News 03/11/11 San Francisco
Exelixis Pockets $156M in Stock Sale, Riding Wave of Prostate Cancer Drug Results 03/09/11 San Francisco
Burrill’s Bet on Seattle, Yamada Exits Gates Foundation, Stewart Parker’s New Gig, & More Seattle-Area Life Sciences News 02/17/11 Seattle
Ivivi Health Adds $4M 02/15/11 San Francisco
AcelRx Gets $40M in IPO 02/11/11 San Francisco
Optimer Nabs $68M in Stock Sale 02/11/11 San Diego
Marina Biotech Nabs $5.1M 02/10/11 Seattle
Fluidigm Raises $75M in Second Chance at IPO 02/10/11 San Francisco
Dendreon Adds $80M, Amgen Advances ‘Son of Dmab,’ Mobisante Wins FDA OK, & More Seattle-Area Life Sciences News 02/10/11 Seattle
Geospiza Gets $1.2M Grant 02/09/11 Seattle
Oncothyreon Secures $12.5M Loan 02/09/11 Seattle
SeaGen Expects $280M Cash at Year End 02/08/11 Seattle
Regulus, the MicroRNA Child of Alnylam and Isis, Offers Litmus Test for Biotech Hope in 2011 02/07/11 San Diego
Dendreon Adds Another $80M 02/03/11 Seattle
SeaGen Tacks on $23M 02/03/11 Seattle
ISB Partners With P&G 02/03/11 Seattle
Seattle Genetics Reloads, Uptake Ups and Leaves, PhysioSonics Raises Cash, & More Seattle-Area Life Sciences News 02/03/11 Seattle
Seattle Genetics Reloads Cash Reserves With $155M, On Cusp of Selling First Drug 02/02/11 Seattle
PhysioSonics, a UW Ultrasound Spinoff, Raises Cash from Medtronic, Kirby Cramer 01/27/11 Seattle
Nektar Pockets $220M 01/24/11 San Francisco
Calypso Pulls in $6.4M 01/21/11 Seattle
Dendreon Rakes in $540M to Seize Opportunity for Provenge in U.S., Europe 01/14/11 Seattle
Page 3 of 11 « previous page · next page »

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.